Marita Ziepert
LHA-ID: 7W2GJTH8AW-5
Location:
DE
Expertise: Not specified
Tools: Not specified
ORCID: Not specified
Project roles
Project administrator
Marita's tagsRelated items
B-cell lymphoma is the most frequent lymphoid neoplasia accounting for one third of all lymphomas. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) is the current treatment standard, leading to high cure rates especially in younger patients. Although the 3-year event-free survival is about 60% even for elderly patients between 60-80 years old, the remainder of patients eventually relapse and the majority die of their disease. The German Non-Hodgkin's Lymphoma Study
...
Programme: NHL
Public web page: https://www.dshnhl.org
Snapshots: No snapshots
The toxcalculator is a web-based tool to calculate prognostic scores on haematopoietic toxicity for 6 cycles CHOP-like regimen in patients with aggressive NHL. The models used for the toxcalculator are based on data obtained in the NHL-B1 and NHL-B2-trials, validated with the RICOVER-60-dataset.
Snapshots: No snapshots
Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.
Person responsible: René Hänsel
Snapshots: No snapshots
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Contributor: Christoph Beger
Assay type: Result Dataset of Clinical Study
Technology type: Technology Type
Snapshots: No snapshots
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Contributor: Christoph Beger
Assay type: Result Dataset of Clinical Study
Technology type: Technology Type
Snapshots: No snapshots
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Contributor: René Hänsel
Assay type: Experimental Assay Type
Technology type: Technology Type
Snapshots: No snapshots
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Trial data as Microsoft Excel file
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Trial data as CDISC ODM file
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Trial data as SPSS file
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Trial data as Microsoft Excel file
DownloadDemographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Trial data as CDISC ODM file
Abstract (Expand)
Authors: K. Hohloch, Samira Zeynalova, B. Chapuy, M. Pfreundschuh, Markus Löffler, Marita Ziepert, A. C. Feller, L. Trumper, D. Hasenclever, G. Wulf, N. Schmitz
Date Published: 12th May 2016
Journal: Ann Hematol
Human Diseases: Not specified
Abstract (Expand)
Authors: K. Hohloch, C. Zwick, Marita Ziepert, D. Hasenclever, U. Kaiser, A. Engert, H. G. Hoffkes, F. Kroschinsky, R. Mesters, A. C. Feller, Markus Löffler, L. Trumper, M. Pfreundschuh
Abstract (Expand)
Authors: Marita Ziepert, D. Hasenclever, E. Kuhnt, B. Glass, N. Schmitz, M. Pfreundschuh, Markus Löffler
Abstract (Expand)
Authors: Marita Ziepert, R. Schmits, L. Trumper, Marita Ziepert, Markus Löffler
Abstract (Expand)
Authors: Samira Zeynalova, Marita Ziepert, Markus Scholz, S. Schirm, C. Zwick, M. Pfreundschuh, Markus Löffler
